Jasbir Seehra

Affiliations

  • Chief Executive Officer at Keros Therapeutics Inc. (KROS), 2024-02-23
  • Director at Eloxx Pharmaceuticals Inc. (ELOX), 2022-06-17
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KROS $16.00 20,000 Officer, Director 243,856 2020-04-13 Filing